Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
This guide analyzes beta values across leading coins to identify those with the lowest market sensitivity. Explore interpretation and strategy tips.
26,618 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A fresh analysis finds the study: bipartisan social security plan to borrow and invest funds would leave taxpayers wi...
A half-century-old rule for scaling software teams is breaking as AI fueled capital changes how firms grow. Investors...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
philly voters approve first city-run retirement program for workers without 401(k) plans, creating PhillySaves to aut...
A traditional publishing house rethinks growth with a bold AI push. A key investor just added $7 million to their sta...
A high-profile legal battle claims a $175 million loss across jewelry, real estate, and jet deals. This piece breaks ...
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
Yatsen's Q1 2026 results are a pivotal signal for the year ahead. This analysis breaks down the earnings narrative, h...
Retirees are weighing 401(K) rollovers to traditional IRAs as SECURE 2.0 tweaks and market volatility shift retiremen...
Doximity sits at a crossroads: a robust physician network with multiple monetization channels, yet facing disruption ...
A prominent AI founder challenges the notion that automation alone boosts margins, revealing a doubled headcount desp...